Biospecimen Procurement for Immuno-Oncology Research
This study aims to collect and store biological samples (like blood and tumor tissue) from people with cancer or pre-cancerous conditions. Researchers want to understand why different cancers respond differently to treatments, especially immunotherapy (treatments that use your body's immune system to fight cancer). By studying these samples, they hope to develop more effective treatments. You can join if you are at least 18 years old and have a diagnosis of cancer, a pre-cancerous condition, or an immune system problem that increases your risk of cancer. The main goal is to acquire these samples for ongoing research.
- Study design
- This is an observational study, meaning no experimental treatments are given. Up to 500 participants will be enrolled.
- What's involved
- You would provide samples such as blood, tumor tissue, and other body fluids. Your diagnosis will be confirmed by the NCI Laboratory of Pathology.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Scott M Norberg, D.O. · PRINCIPAL_INVESTIGATOR · National Cancer Institute (NCI)
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Sample AcquisitionOngoing
Biospecimen collection for study and understanding of disease.